Edition:
United Kingdom

Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone


Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Resverlogix Corp :Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone.Resverlogix - ‍independent DSMB recommended phase 3 study of Apabetalone should continue as planned without modifications ​.Resverlogix Corp - ‍full enrollment for phase 3 study of apabetalone now anticipated in first half of 2018​. 

Company Quote

2.87
0.02 +0.70%
8:55pm BST